263 related articles for article (PubMed ID: 32601463)
1. Tumour budding and its clinical implications in gastrointestinal cancers.
Zlobec I; Berger MD; Lugli A
Br J Cancer; 2020 Sep; 123(5):700-708. PubMed ID: 32601463
[TBL] [Abstract][Full Text] [Related]
2. Tumour budding in solid cancers.
Lugli A; Zlobec I; Berger MD; Kirsch R; Nagtegaal ID
Nat Rev Clin Oncol; 2021 Feb; 18(2):101-115. PubMed ID: 32901132
[TBL] [Abstract][Full Text] [Related]
3. Taking tumour budding to the next frontier - a post International Tumour Budding Consensus Conference (ITBCC) 2016 review.
Studer L; Blank A; Bokhorst JM; Nagtegaal ID; Zlobec I; Lugli A; Fischer A; Dawson H
Histopathology; 2021 Mar; 78(4):476-484. PubMed ID: 33001500
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Lugli A; Kirsch R; Ajioka Y; Bosman F; Cathomas G; Dawson H; El Zimaity H; Fléjou JF; Hansen TP; Hartmann A; Kakar S; Langner C; Nagtegaal I; Puppa G; Riddell R; Ristimäki A; Sheahan K; Smyrk T; Sugihara K; Terris B; Ueno H; Vieth M; Zlobec I; Quirke P
Mod Pathol; 2017 Sep; 30(9):1299-1311. PubMed ID: 28548122
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumor budding in gastrointestinal tumors.
Märkl B; Arnholdt HM
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1521-33. PubMed ID: 21999126
[TBL] [Abstract][Full Text] [Related]
6. Pattern and Significance of Tumour Budding in Colorectal Carcinomas Using ITBCC Guidelines: a Low Resource Setting Practice Observation.
Ezenkwa US; Ogun GO; Bamiro OO; Mashor MI; Okolo CA; Adegoke OO; Ogunbiyi OJ
J Gastrointest Cancer; 2020 Sep; 51(3):1018-1023. PubMed ID: 31970654
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
Ulase D; Heckl S; Behrens HM; Krüger S; Röcken C
Histopathology; 2020 Feb; 76(3):433-446. PubMed ID: 31538348
[TBL] [Abstract][Full Text] [Related]
8. Tumour budding in colorectal cancer: what do we know and what can we do?
De Smedt L; Palmans S; Sagaert X
Virchows Arch; 2016 Apr; 468(4):397-408. PubMed ID: 26613731
[TBL] [Abstract][Full Text] [Related]
9. Potential clinical scenarios of tumour budding in colorectal cancer.
Dawson H; Blank A; Zlobec I; Lugli A
Acta Gastroenterol Belg; 2019; 82(4):515-518. PubMed ID: 31950807
[TBL] [Abstract][Full Text] [Related]
10. Tumor budding in colorectal cancer--ready for diagnostic practice?
Koelzer VH; Zlobec I; Lugli A
Hum Pathol; 2016 Jan; 47(1):4-19. PubMed ID: 26476568
[TBL] [Abstract][Full Text] [Related]
11. Pathologist's perspectives on reporting of tumour budding in colorectal cancer.
Roya P; Zameer L; Dey D; Datta J; Bardia A; Mishra D
Ecancermedicalscience; 2021; 15():1337. PubMed ID: 35211206
[TBL] [Abstract][Full Text] [Related]
12. Tumor Budding in Colorectal Carcinoma: Translating a Morphologic Score Into Clinically Meaningful Results.
Cho SJ; Kakar S
Arch Pathol Lab Med; 2018 Aug; 142(8):952-957. PubMed ID: 30040461
[TBL] [Abstract][Full Text] [Related]
13. Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung-a single-center analysis of 354 cases.
Neppl C; Zlobec I; Schmid RA; Berezowska S
Mod Pathol; 2020 May; 33(5):802-811. PubMed ID: 31796876
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumour budding in noncolorectal gastrointestinal tract and pancreatobiliary tract: a systematic review and meta-analysis.
Park JH; Shin JI; Lim BJ
Histopathology; 2024 Jun; 84(7):1079-1091. PubMed ID: 38362762
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
[TBL] [Abstract][Full Text] [Related]
16. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
[TBL] [Abstract][Full Text] [Related]
17. Improving tumor budding reporting in colorectal cancer: a Delphi consensus study.
Haddad TS; Lugli A; Aherne S; Barresi V; Terris B; Bokhorst JM; Brockmoeller SF; Cuatrecasas M; Simmer F; El-Zimaity H; Fléjou JF; Gibbons D; Cathomas G; Kirsch R; Kuhlmann TP; Langner C; Loughrey MB; Riddell R; Ristimäki A; Kakar S; Sheahan K; Treanor D; van der Laak J; Vieth M; Zlobec I; Nagtegaal ID
Virchows Arch; 2021 Sep; 479(3):459-469. PubMed ID: 33650042
[TBL] [Abstract][Full Text] [Related]
18. Reporting of tumor budding in colorectal adenocarcinomas using ×40 objective: A practical approach for resource constrained set-ups.
Roy P; Datta J; Roy M; Mallick I; Mohandas M
Indian J Cancer; 2017; 54(4):640-645. PubMed ID: 30082550
[TBL] [Abstract][Full Text] [Related]
19. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
[TBL] [Abstract][Full Text] [Related]
20. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
